Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy
Optimization of a more sensitive assay is warranted as CSF cytokine concentrations have high potential to be used as biomarkers to characterize neuroinflammation in equine neurological diseases.
Authors
- Amy L. Johnson
- Rebecca E. Ruby (ORCID: https://orcid.org/0000-0002-1113-6566)
- Darko Stefanovski (ORCID: https://orcid.org/0000-0002-4654-0569)
- Flavie Payette (ORCID: https://orcid.org/0009-0006-0358-0698)
- Jennifer Janes (ORCID: https://orcid.org/0000-0002-2654-7421)
- Jennifer Morrow
- Amy J. Graves
- K. B. Orr
- Stephen M. Reed
- Jeaneen Kulp
Institutions
- University of Kentucky (US)
- Rood and Riddle Equine Hospital (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- American Journal of Veterinary Research
- Published
- 2025-09-05
- DOI
- https://doi.org/10.2460/ajvr.25.06.0212
- Primary Topic
- Neurological diseases and metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00